Efficacy and safety of first-line immunotherapy and targeted therapy in advanced HCC: a network meta-analysis with subgroup analysis based on HBV and HCV infection

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-01-29
DOI
https://doi.org/10.3389/fimmu.2026.1706446
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
24.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of first-line immunotherapy and targeted therapy in advanced HCC: a network meta-analysis with subgroup analysis based on HBV and HCV infection

Haowei Ma, Wei Chen, Qinfei Li, Hong Li
1 citations
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
24.20
article

Efficacy and safety of first-line immunotherapy and targeted therapy in advanced HCC: a network meta-analysis with subgroup analysis based on HBV and HCV infection

Haowei Ma, Wei Chen, Qinfei Li, Hong Li
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
University of Wisconsin–Madison (US), Duquesne University (US), United General Hospital (US), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 2%
Cancer Immunotherapy and Biomarkers
24.20
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.